Inventor · disambiguated record
Pei-Hua Lin
Also filed as: Lin pei-hua
7 granted patents·11 pending applications·15 citations·filing 2012–2025
77Inventor score
Files withSHANGHAI HENLIUS BIOTECH INC11UNIV NAT CHUNG HSING3CHIOU SHIOW-HER1EXCELLIANCE MOS CORP1HENLIUS BIOTECH CO LTD1
Top patents by PatentIndex Score
18 records- 0187US10336801B2Chemokine-cytokine fusion proteins of SDF-1 and CD40LUNIV NAT CHUNG HSING·Filed 2017·Granted Jul 2, 2019·12 cites·3 claims
- 0281US11274155B2Anti-PD-L1 antibodies and variantsSHANGHAI HENLIUS BIOTECH INC·Filed 2019·Granted Mar 15, 2022·2 cites·13 claims
- 0373US2023265150A1A fusion proteon of stromal cell-derived factor-1 (sdf-1) and interleukin-2 (il-2) and applications thereofUNIV NAT CHUNG HSING·Filed 2023·Application pending·0 cites
- 0466US11618786B2Anti-PD-L1 antibodies and variantsSHANGHAI HENLIUS BIOTECH INC·Filed 2022·Granted Apr 4, 2023·0 cites·23 claims
- 0566US2024383995A1Anti-ox40 antibodies and methods of useSHANGHAI HENLIUS BIOTECH INC·Filed 2024·Application pending·0 cites
- 0666US2024383996A1Anti-ox40 antibodies, multispecific antibodies and methods of useSHANGHAI HENLIUS BIOTECH INC·Filed 2024·Application pending·0 cites
- 0763US11685783B2Anti-PD-1 antibodiesSHANGHAI HENLIUS BIOTECH INC·Filed 2021·Granted Jun 27, 2023·0 cites·15 claims
- 0863US2025019459A1Anti-msln antibodies and methods of useSHANGHAI HENLIUS BIOTECH INC·Filed 2024·Application pending·0 cites
- 0962US11261255B2Anti-epidermal growth factor receptor (EGFR) antibodiesSHANGHAI HENLIUS BIOTECH INC·Filed 2020·Granted Mar 1, 2022·0 cites·14 claims
- 1061US10584171B2Anti-epidermal growth factor receptor (EGFR) antibodiesHENLIX BIOTECH CO LTD·Filed 2015·Granted Mar 10, 2020·1 cites·76 claims
- 1160US11028173B2Anti-PD-1 antibodiesSHANGHAI HENLIUS BIOTECH INC·Filed 2019·Granted Jun 8, 2021·0 cites·18 claims
- 1259US2025380495A1Transistor structureEXCELLIANCE MOS CORP·Filed 2024·Application pending·0 cites
- 1359US2019270788A1Chemokine-cytokine fusion proteins and their applicationsUNIV NAT CHUNG HSING·Filed 2019·Application pending·0 cites
- 1456US2025320297A1Anti-pdl1 antibodies and methods of useSHANGHAI HENLIUS BIOTECH INC·Filed 2025·Application pending·0 cites
- 1553US2025326848A1Anti-pdl1 antibodies, multispecific antibodies and methods of useSHANGHAI HENLIUS BIOTECH INC·Filed 2025·Application pending·0 cites
- 1650US2015307577A1Chemokine-cytokine fusion proteins and their applicationsCHIOU SHIOW-HER·Filed 2012·Application pending·0 cites
- 1749US2025243278A1Anti-b7h3 antibodies and methods of useSHANGHAI HENLIUS BIOTECH INC·Filed 2025·Application pending·0 cites
- 1835US2018193456A1Anti-vascular endothelial growth factor receptor 2 (vegfr2) antibodiesHENLIUS BIOTECH CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pei-Hua Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →